These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31932772)

  • 1. Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds.
    Zhang DKY; Cheung AS; Mooney DJ
    Nat Protoc; 2020 Mar; 15(3):773-798. PubMed ID: 31932772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells.
    Cheung AS; Zhang DKY; Koshy ST; Mooney DJ
    Nat Biotechnol; 2018 Feb; 36(2):160-169. PubMed ID: 29334370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane.
    Giannoni F; Barnett J; Bi K; Samodal R; Lanza P; Marchese P; Billetta R; Vita R; Klein MR; Prakken B; Kwok WW; Sercarz E; Altman A; Albani S
    J Immunol; 2005 Mar; 174(6):3204-11. PubMed ID: 15749850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the requirement of antigen-presenting cells for long-term growth among cytomegalovirus-specific Th clonotypes.
    Santamaria P; Lewis C; Barbosa JJ
    Eur J Immunol; 1993 Nov; 23(11):2972-9. PubMed ID: 8223874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-mimicking scaffolds for ex vivo T cell expansion.
    Kim HS; Ho TC; Willner MJ; Becker MW; Kim HW; Leong KW
    Bioact Mater; 2023 Mar; 21():241-252. PubMed ID: 36157246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
    Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
    Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
    Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
    Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens.
    Zeng W; Su M; Anderson KS; Sasada T
    Immunobiology; 2014 Aug; 219(8):583-92. PubMed ID: 24713579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
    Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
    J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
    Rudolf D; Silberzahn T; Walter S; Maurer D; Engelhard J; Wernet D; Bühring HJ; Jung G; Kwon BS; Rammensee HG; Stevanović S
    Cancer Immunol Immunother; 2008 Feb; 57(2):175-83. PubMed ID: 17657490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Antigen-Presenting Cells for Adoptive T Cell Therapy.
    Dahotre SN; Romanov AM; Su FY; Kwong GA
    Adv Ther (Weinh); 2021 Aug; 4(8):. PubMed ID: 34541300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines.
    Chakraborty NG; Li L; Sporn JR; Kurtzman SH; Ergin MT; Mukherji B
    J Immunol; 1999 May; 162(9):5576-83. PubMed ID: 10228040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
    Jaiswal AI; Dubey C; Swain SL; Croft M
    Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells.
    Steenblock ER; Fahmy TM
    Mol Ther; 2008 Apr; 16(4):765-72. PubMed ID: 18334990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-presenting function of the macrophage.
    Unanue ER
    Annu Rev Immunol; 1984; 2():395-428. PubMed ID: 6242349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.
    Irlé C; Jaques D; Tiercy JM; Fuggle SV; Gorski J; Termijtelen A; Jeannet M; Mach B
    J Exp Med; 1988 Mar; 167(3):853-72. PubMed ID: 2450955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
    Schultze JL; Michalak S; Seamon MJ; Dranoff G; Jung K; Daley J; Delgado JC; Gribben JG; Nadler LM
    J Clin Invest; 1997 Dec; 100(11):2757-65. PubMed ID: 9389740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.